CClinicalTrials.gg
CompletedNCT06693635Updated Jan 1, 2025

Comparative Evaluation of Implant Planning Software

An observational study in Edentulous Jaw, Edentulous Alveolar Ridge and Edentulous Mouth, sponsored by University of Bari Aldo Moro. Completed at 1 site in Italy. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-01-01.

Sponsored by University of Bari Aldo Moro · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
1
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Artificial intelligence (AI) is increasingly being integrated into dental implant planning, revolutionizing the way clinicians approach treatment. AI-driven software can enhance the accuracy of implant placement by analyzing complex data sets, including bone density, anatomical structures, and patient-specific factors. This technology enables the creation of precise 3D models and surgical guides, facilitating more predictable and personalized treatment outcomes. Additionally, AI algorithms can automate tasks such as segmentation, matching digital impressions with CBCT scans, and even suggesting optimal implant positions. The integration of AI in implant planning not only improves clinical efficiency but also contributes to better patient outcomes by reducing surgical risks and enhancing the overall success of implant procedures.

02

Conditions studied

  • Edentulous Jaw
  • Edentulous Alveolar Ridge
  • Edentulous Mouth
  • Partial-edentulism

Keywords

  • Artificial Intelligence in Implantology
  • AI
  • Implant planning
  • AI software
03

In context

Jaw, Edentulous

171 studies on the registry are indexed under Jaw, Edentulous; 24 are open to participants now.

This study's enrollment of 1 is below the median of 40 across 25 observational studies indexed under Jaw, Edentulous.

Browse Jaw, Edentulous studies →

Lead sponsor

University of Bari Aldo Moro is the lead sponsor of 29 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

All patients requiring implant rehabilitation with digital planning

Inclusion criteria

  • CBCT of Patient who needs Implant rehabilitations

Exclusion criteria

Exclusion Criteria:

  • Patient not suitable for implant rehabilitation
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
1 participant (actual)
Patient registry
No

Interventions

  • Diagnostic testImplant planning

    The implant planning will be carried out using various software programs. The AI assistance provided by each software will be evaluated.

06

What researchers measure

Primary outcomes

  1. Segmentation of Bones

    The segmentation of bone structures and anatomical boundaries performed by the software will be evaluated.

    Time frame: 1 day

  2. Recognition of Neural structure

    The segmentation and recognition of nerve structures performed by the software will be evaluated.

    Time frame: 1 day

  3. Segmentation of teeth

    The segmentation of teeth performed by the software will be evaluated.

    Time frame: 1 day

  4. Bone density

    The bone hardness and density data will be evaluated at three different points. The value will be given on the Hounsfield Scale.

    Time frame: 1 day

  5. Time Workflow

    The execution time of each planning will be evaluated.

    Time frame: 1 day

07

Study locations

1 site
  • University of Bari Aldo Moro
    Bari, 70124, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06693635
Lead sponsor
University of Bari Aldo Moro
Responsible party
Giuseppe D'Albis (DDS, MSc, University of Bari Aldo Moro) — Principal investigator
First posted
Nov 18, 2024
Start date
Nov 1, 2024
Primary completion
Nov 1, 2024
Completion
Nov 1, 2024
Last update
Jan 1, 2025

Study contacts

Giuseppe D'Albis, Dr
principal investigator · University of Bari Aldo Moro
Massimo Corsalini, Prof
study director · University of Bari Aldo Moro
Saverio Capodiferro, Prof
study director · University of Bari Aldo Moro

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion